The federal government has announced the listing of a new treatment in the Pharmaceutical Benefits Scheme [[P-B-S]] for patients suffering from advanced melanoma. The drug called Opdualag is set to be listed under the PBS from February 1 as part of the government's expansion of the national scheme.
Cancer experts want free screenings for high-risk patients to detect deadly melanomas before they take hold, as people delay checks due to the rising out-of-pocket cost.
Cancer experts want free screenings for high-risk patients to detect deadly melanomas before they take hold, as people delay checks due to the rising out-of-pocket cost.
Cancer experts want free screenings for high-risk patients to detect deadly melanomas before they take hold, as people delay checks due to the rising out-of-pocket cost.